Lexicon Pharmaceuticals
LXRX
#6159
Rank
HK$8.28 B
Marketcap
HK$18.66
Share price
2.15%
Change (1 day)
93.25%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -HK$0.21 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are HK$69.64 Million. In 2025 the company made an earning of -HK$0.4 Billion, an increase over its 2024 earnings that were of -HK$1.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.21 Billion-48.6%
2025 -HK$0.4 Billion-74.88%
2024 -HK$1.58 Billion13.15%
2023 -HK$1.39 Billion73.74%
2022 -HK$0.8 Billion16.16%
2021 -HK$0.69 Billion49.82%
2020 -HK$0.46 Billion-147.19%
2019 HK$0.97 B-203.42%
2018 -HK$0.95 Billion-15.31%
2017 -HK$1.12 Billion0.2%
2016 -HK$1.11 Billion2920.7%
2015 -HK$36.71 Million-95.33%
2014 -HK$0.79 Billion-3.61%
2013 -HK$0.82 Billion-5.52%
2012 -HK$0.87 Billion-4.17%
2011 -HK$0.91 Billion15.5%
2010 -HK$0.79 Billion8.36%
2009 -HK$0.73 Billion-4.81%
2008 -HK$0.76 Billion28.79%
2007 -HK$0.59 Billion35.71%
2006 -HK$0.44 Billion52.91%
2005 -HK$0.29 Billion-23.89%
2004 -HK$0.38 Billion-24.19%
2003 -HK$0.5 Billion-0.48%
2002 -HK$0.5 Billion44.12%
2001 -HK$0.35 Billion23.01%
2000 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
HK$58.18 B-28,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.09 B-4,546.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$40.42 B-19,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$4.21 Billion 1,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$1.49 B-830.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$0.62 B-404.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$0.19 Billion-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.02 B-1,577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$0.12 Billion-42.82%๐Ÿ‡บ๐Ÿ‡ธ USA